Repaglinide
- Product NDC
- 57664-745
- 11-digit product format
- 576640745
- Labeler code
- 57664
- Product ID
- 57664-745_ef7cf939-f51c-47f9-bf9e-a36f1b94daac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA077571
- Marketing category
- ANDA
- Marketing start
- 2013-07-11
- Marketing end
- 0000-00-00
- Substance
- REPAGLINIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Glinide [EPC],Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 57664-745-13 | 57664074513 | 500 TABLET in 1 BOTTLE (57664-745-13) | 500 tablet | 2013-07-11 | 0000-00-00 | No | No | Current |
| 57664-745-18 | 57664074518 | 1000 TABLET in 1 BOTTLE (57664-745-18) | 1000 tablet | 2013-07-11 | 0000-00-00 | No | No | Current |
| 57664-745-88 | 57664074588 | 100 TABLET in 1 BOTTLE (57664-745-88) | 100 tablet | 2013-07-11 | 0000-00-00 | No | No | Current |